留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

磁共振成像在宫颈癌的临床应用

任翠 薛华丹

任翠, 薛华丹. 磁共振成像在宫颈癌的临床应用[J]. 协和医学杂志, 2011, 2(3): 277-280. doi: 10.3969/j.issn.1674-9081.2011.03.018
引用本文: 任翠, 薛华丹. 磁共振成像在宫颈癌的临床应用[J]. 协和医学杂志, 2011, 2(3): 277-280. doi: 10.3969/j.issn.1674-9081.2011.03.018

磁共振成像在宫颈癌的临床应用

doi: 10.3969/j.issn.1674-9081.2011.03.018
详细信息
    通讯作者:

    薛华丹 电话:010-65295509, E-mail:bjdanna95@hotmail.com

  • 中图分类号: R445.2;R737.3

  • [1] Scheidler J, Heuck AF. Imaging of cancer of the cervix[J]. Radiol Clin North Am, 2002, 40:577-590. doi:  10.1016/S0033-8389(01)00007-0
    [2] Odicino F, Tisi G, Rampinelli F, et al. New development of the FIGO staging system[J]. Gynecol Oncol, 2007, 107:S8-S9. doi:  10.1016/j.ygyno.2007.07.018
    [3] Bhosale P, Peunqiesada S, Devine C, et al. Role of magnetic resonance imaging as an adjunct to clinical staging in cervical carcinoma[J]. J Comput Assist Tomogr, 2010, 34:855-864. doi:  10.1097/RCT.0b013e3181ed3090
    [4] Balleyguier C, Sala E, Da Cunha T, et al. Staging of uterine cervical cancer with MRI:guidelines of the European Society of Urogenital Radiology[J]. Eur Radiol, 2011, 21:1102-1110. doi:  10.1007/s00330-010-1998-x
    [5] Ascher SM, Takahama J, Jha RC. Staging of gynecologic malignancies[J]. Top Magn Reson Imaging, 2001, 12:105-129. doi:  10.1097/00002142-200104000-00004
    [6] Okamoto Y, Tanaka YO, Nishida M, et al. MR imaging of the uterine cervix:imaging-pathologic correlation[J]. Radiographics, 2003, 23:425-445; quiz 534-535. doi:  10.1148/rg.232025065
    [7] Manfredi R, Gui B, Giovanzana1 A, et al. Localized cervical cancer (stage < IIB):accuracy of MR imaging in planning less extensive surgery[J]. Radiol Med, 2009, 114:960-975. doi:  10.1007/s11547-009-0397-3
    [8] deSouza NM, Dina R, Meindoe GA, et al. Cervical cancer:value of an endovagihal coil magnetic resonance imaging techniqu in detecting small volume disease and assessing parametrial extension[J]. Gyneeol Oneoi, 2006, 102:80-85. http://europepmc.org/abstract/med/16427688
    [9] Chiang SH, Quek ST. Carcinoma of the cervix:role of MR imaging[J]. Ann Acad Med Singapore, 2003, 32:550-556. http://www.ncbi.nlm.nih.gov/pubmed/12968563
    [10] Follen M, Levenback CF, Iyer RB, et al. Imaging in cervical cancer[J]. Cancer. 2003, 98:2028-2038. doi:  10.1002/cncr.11679
    [11] Iwata S, Joja I, Okuno K, et al. Cervical carcinoma with full-thickness stromal invasion:efficacy of dynamic MR imaging in the assessment of parametrial involvement[J]. Radiat Med, 2002, 20:247-255. http://www.ncbi.nlm.nih.gov/pubmed/12450104/
    [12] 张婷, 刘爱连, 汪禾青, 等. MRI动态增强扫描对宫颈癌的诊断价值[J].中华放射学杂志, 2009, 43:973-977. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhfsx200909018
    [13] Van Hoe L, Vanbeckevoort D, Oyen R, et al. Cervical carcinoma:optimized local staging with intra-vaginal contrastenhanced MR imaging-preliminary results[J]. Radiology, 1999, 213:608-611. doi:  10.1148/radiology.213.2.r99oc23608
    [14] Haider MA, Sitartchouk I, Roberts TP, et al. Correlations between dynamic contrast-enhanced magnetic resonance imaging-derived measures of tumour microvasculature and interstitial fluid pressure in patients with cervical cancer[J]. J Magn Reson Imaging, 2007, 25:153-159. doi:  10.1002/jmri.20795
    [15] Nicolet V, Carignan L, Bourdon F, et al. MR imaging of cervical carcinoma:a practical staging approach[J]. Radiographics, 2000, 20:1539-1549. doi:  10.1148/radiographics.20.6.g00nv111539
    [16] Rezvani M, Shaaban A. Imaging of cervical pathology[J]. Clin Obstet Gynecol, 2009, 52:94-111. doi:  10.1097/GRF.0b013e31819617f1
    [17] Bipat S, Glas AS, van der Velden J, et al. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma:a systematic review[J]. Gynecol Oncol, 2003, 91:59-66. doi:  10.1016/S0090-8258(03)00409-8
    [18] Rockall AG, Sohaib SA, Harisinghani MG, et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymphnode metastases in patients with endometrial and cervical cancer[J]. J Clin Oncol, 2005, 20:2813-2821. http://www.ncbi.nlm.nih.gov/pubmed/15837995
    [19] Choi HJ, Kim SH, Seo SS, et al. MRI for pretreatment lymph node staging in uterine cervical cancer[J]. AJR Am J Roentgenol, 2006, 187:538-543. doi:  10.2214/AJR.05.0263
    [20] Xue HD, Li S, Sun F, et al. Clinical application of body diffusion weighted MR imaging in the diagnosis and preoperative N staging of cervical cancer[J]. Chin Med Sci J, 2008, 23:133-137. doi:  10.1016/S1001-9294(09)60027-4
    [21] Choi EK, Kim JK, Choi HJ, et al. Node-by-node correlation between MR and PET/CT in patients with uterine cervical cancer:diffusion-weighted imaging versus size-based criteria on T2WI[J]. Eur Radiol, 2009, 19:2024-2032. doi:  10.1007/s00330-009-1350-5
    [22] Liu Y, Liu H, Bai X, et al. Differentiation of metastatic from non-metastatic lymph nodes in patients with uterine cervical cancer using diffusion-weighted imaging[J]. Gynecol Oncol, 2011, 122:19-24. doi:  10.1016/j.ygyno.2011.03.023
    [23] Engin G. Cervical cancer:MR imaging findings before, during, and after radiation therapy[J]. Eur Radiol, 2006, 16:313-324. doi:  10.1007/s00330-005-2804-z
    [24] Koh DM, Collins DJ. Diffusion-weighted MRI in the body:applications and challenges inoncology[J]. AJR Am J Roentgenol, 2007, 188:1622-1635. doi:  10.2214/AJR.06.1403
    [25] Moffat BA, Chenevert TI, Lawrence TS, et al. Functiona diffusion map:a noninvasive MRI biomarker for early stratificat of clinical brain tumor response[J]. Proc Natl Acad Sci USA, 2005, 102:5524-5529. doi:  10.1073/pnas.0501532102
    [26] Gesehwind JF, Artemov D, Abraham S, et al. Chemoembolization of liver tumor in a rabbit model:assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis[J]. J Vase Interv Radio1, 2000, 11:1245-1255. doi:  10.1016/S1051-0443(07)61299-8
    [27] Rizzol S, Summers P, Raimondi S, et al. Diffusion-weighted MR imaging in assessing cervical tumour response to nonsurgical therapy[J]. Radiol Med, (2011-03-07). http://www.springerlink.com/content/42602023562g4185/.
    [28] Harry VN, Semple SI, Gilbert FJ, et al. Diffusion-weighted magnetic resonance imaging in the early detection of respose to chemoradiation in cervical cancer[J]. Gynecol Oncol, 2008, 111:213-220. doi:  10.1016/j.ygyno.2008.07.048
    [29] Mayr NA, Wang JZ, Zhang D, et al. Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer[J]. Int J Radiat Oncol Biol Phys, 2010, 77:502-508. doi:  10.1016/j.ijrobp.2009.04.084
    [30] Mahon MM, Cox IJ, Dina R, et al. (1) H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer:in vivo-ex vivo pro? les and effect of tumor load[J]. J Magn Reson Imaging, 2004, 19:356-364. doi:  10.1002/jmri.20012
    [31] Mahon MM, Williams AD, Soutter WP, et al. 1H magnetic resonance spectroscopy of invasive cervical cancer:an in vivo study with ex vivo corroboration[J]. NMR Biomed, 2004, 17:1-9. doi:  10.1002/nbm.830
    [32] deSouza NM, Soutter WP, Rustin G, et al. Use of neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer:monitoring tumour shrinkage and molecular pro? le on magnetic resonance and assessment of 3-year outcome[J]. Br J Cancer, 2004, 90:2326-2331. doi:  10.1038/sj.bjc.6601870
  • 加载中
计量
  • 文章访问数:  298
  • HTML全文浏览量:  95
  • PDF下载量:  7
  • 被引次数: 0
出版历程
  • 收稿日期:  2011-05-18
  • 刊出日期:  2011-07-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!